Sorry – wrong addressee [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2024-07-24 15:31 (254 d 03:03 ago) – Posting: # 24099
Views: 2,328

Hi QA,

❝ ❝ IMHO, such a product is a mere marketing gimmick.❝

❝ Thank you for your HO. Let the BD and marketing team take the call.

Sure. At the end of the day the ‘Guy in the Armani suit’ decides.

❝ Allow me to ask the same question. As a strategy to register this product in EU, what is your suggestion?

I’m not the best person to support something that I cannot scientifically defend.
To give you an example: I was once asked by an innovator to develop the concept for a modified (i.e., prolonged) release formulation of a drug with a half-life of > 48 hours, which is only administered chronically. Doesn’t make any sense – a clear case of evergreening. BE of MR is much more difficult than the one of IR.
Not my circus, not my monkeys. I refused.
🙈 🙉 🙊

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,413 posts in 4,924 threads, 1,668 registered users;
64 visitors (0 registered, 64 guests [including 5 identified bots]).
Forum time: 18:35 CEST (Europe/Vienna)

Nothing shows a lack of mathematical education more
than an overly precise calculation.    Carl Friedrich Gauß

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5